Company Filing History:
1 out of 111 
1 out of 5,094 
1 out of 4 Years Active: 2019
Title: Marie-Dominique Galibert: Innovator in Melanoma Research
Introduction
Marie-Dominique Galibert is a prominent inventor based in Rennes, France. She has made significant contributions to the field of melanoma research, particularly through her innovative approaches to treatment and patient management. Her work focuses on understanding the complexities of melanoma aggressiveness and developing methods to improve patient outcomes.
Latest Patents
Marie-Dominique Galibert holds a patent for her invention titled "TYRP1, a natural miRNA sponge, and its use in managing human melanoma aggressiveness." This invention relates to methods and reagents for treating melanoma and metastatic melanoma by targeting the TYRP1 RNA transcript. It also includes methods for predicting a patient's therapeutic response and assessing the effectiveness of treatment. Furthermore, her invention introduces a combination of biological markers that can predict the survival of melanoma patients, regardless of the treatment administered.
Career Highlights
Throughout her career, Marie-Dominique has worked with esteemed institutions such as Université de Rennes 1 and the Centre National de la Recherche Scientifique. Her research has been pivotal in advancing the understanding of melanoma and developing new therapeutic strategies.
Collaborations
Marie-Dominique has collaborated with notable colleagues, including David Gilot and Ghanem Ghanem. These partnerships have enriched her research and contributed to the advancement of melanoma treatment methodologies.
Conclusion
Marie-Dominique Galibert's innovative work in melanoma research exemplifies her commitment to improving patient care through scientific discovery. Her contributions continue to influence the field and offer hope for better treatment options for melanoma patients.